Skip to main content
The NCI Community Hub will be retiring in May 2024. For more information please visit the NCIHub Retirement Page:https://ncihub.cancer.gov/groups/ncihubshutdown/overview
close

Resources: All

Submit a resource

Find a resource
  1. nanoparticles x
  2. bioinformatics x
  3. cancer x
  4. breastcancer x
  5. cwig x

  1. CWIG_March13th2020_Evans_MGH_ContainersPipeline_Slides

    0.0 out of 5 stars 

    04 Nov 2020

  2. CWIG_May08th2020-DavidGodlove_Slides

    0.0 out of 5 stars 

    04 Nov 2020

  3. CWIG_May08th2020_DavidGodlove_Recording

    0.0 out of 5 stars 

    04 Nov 2020

  4. CWIG_May10th2020_RedHat_Recording

    0.0 out of 5 stars 

    04 Nov 2020

  5. CWIG_Nov08th2019_Pathos_Doig_Slides

    0.0 out of 5 stars 

    04 Nov 2020

  6. CWIG_Nov08th2020_PathOS_Recording

    0.0 out of 5 stars 

    04 Nov 2020

  7. CWIG_Oct09th2020_Tibanna_SooLee_Recording

    0.0 out of 5 stars 

    04 Nov 2020

  8. CWIG_OCT11th2020_JohannesKoster-Recording

    0.0 out of 5 stars 

    04 Nov 2020

  9. CWIG_Oct152019_PDCIntegrationSBG_Slides

    0.0 out of 5 stars 

    04 Nov 2020

  10. CWIG_Sept11th2020_Avi Ma'ayan_Recording

    0.0 out of 5 stars 

    04 Nov 2020

  11. CWIG_Sept13th2019_McKerrow_IntegratingMultiOmics_Slides

    0.0 out of 5 stars 

    04 Nov 2020

  12. CWIG_Sept13th2019_SBG_Recording

    0.0 out of 5 stars 

    04 Nov 2020

  13. Dataset Curation, Assessment of their Quality, and Prediction Model Developments for Safe and Sustainable Nanotechnology (S2NANO)

    0.0 out of 5 stars 

    29 Nov 2018 | Presentations | Contributor(s): Tae Hyun Yoon

    Nano WG November 29, 2018: Tae Hyun Yoon, Prof./CEO/Ph.D., Yoon Idea Lab. Co. Ltd. & Hanyang University In this presentation, I will introduce our recent research outcomes from S2NANO: PredictNANO project, which aimed to bridge the nanosafety knowledge gaps between R&D...

  14. Dissolution as a Paradigm in Regulating Nanomaterials

    0.0 out of 5 stars 

    16 Aug 2017 | Presentations | Contributor(s): Frederick C. Klaessig

    Nano WG presentation, August 10, 2017 Themes: • Dissolution as a decision criterion • Analogies to ζ-potential & VSSA • Relation to nanoform & nanoscale form • Dissolution kinetics and artifacts • ASTM particle ontology & Nanoinformatics Roadmap...

  15. European Chemical Agency's work to implement REACH regulation for nanomaterials

    0.0 out of 5 stars 

    04 May 2017 | Presentations | Contributor(s): Frank Le Curieux

    Nano WG presentation on May 4, 2017.  REACH = Registration, Evaluation, Authorisation (& restriction) of Chemicals aims to ensure a high level of protection of human health and the environment while enhancing competitiveness and innovation. Nano materials are covered by...

  16. FAIR for NanoSafety: where do we stand?

    0.0 out of 5 stars 

    05 Apr 2019 | Presentations | Contributor(s): Egon Willighagen

    Nano WG April 4, 2019 Findable, Accessible, Interoperable, Reusable (FAIR) sharing of nanosafety data.

  17. Human Disease Ontology

    0.0 out of 5 stars 

    21 Sep 2016 | External Applications | Contributor(s): Lynn Schriml

    The Disease Ontology has been developed as a standardized ontology for human disease, since 2003, with the purpose of providing the biomedical community with manual curated, consistent, reusable and sustainable descriptions of human disease terms, phenotype characteristics and related...

  18. Informatics to enable Routine Personalized Cancer Therapy (IPCT)

    0.0 out of 5 stars 

    18 Feb 2014 | Presentations | Contributor(s): Elmer V. Bernstam, Funda Meric-Bernstam

  19. Informatics Tools for High-throughput Analysis of Cancer Mutations

    0.0 out of 5 stars 

    15 Jan 2014 | Presentations | Contributor(s): Michael C Ryan, Rachel Karchin

  20. Integrated analysis of breast cancer cell lines reveals unique signaling pathways

    0.0 out of 5 stars 

    16 Sep 2014 | Publications | Contributor(s): Laura M Heiser, Nicholas J Wang, Carolyn L Talcott, Keith R Laderoute, Merrill Knapp, Yinghui Guan, Zhi Hu, Safiyyah Ziyad, Barbara L Weber, Sylvie Laquerre, Jeffrey R Jackson, Richard F Wooster, Wen Lin Kuo, Joe W Gray, Paul T Spellman

    AbstractBackgroundCancer is a heterogeneous disease resulting from the accumulation of genetic defects that negatively impact control of cell division, motility, adhesion and apoptosis. Deregulation in signaling along the EgfR-MAPK pathway is common in breast cancer, though the manner in which...